FSGCY yields 4.63% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, FSGCY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FSGCY + PFE for your $10,000?
First Gen Corporation, through its subsidiaries, engages in the power generation business in Philippines. It operates through FGPC, FGP, FNPC, Prime Meridian, EDC and Subsidiaries, and FG Hydro segments. The FGPC segment operates Santa Rita, a 1,000 MW combined cycle, natural gas-fired power plant. The FGP segment operates San Lorenzo, a 500 MW combined cycle, natural gas-fired power plant. The FNPC segment owns and operates San Gabriel plant, a 420 MW natural gas-fired power plant. The Prime Meridian segment owns and operates Avion plant, a 97 MW open-cycle natural gas-fired power plant. The EDC and Subsidiaries segment holds service contracts with the Department of Energy to explore, develop, and utilize the resources in the relevant 10 geothermal contract areas. This segment owns and operates 588.4 MW Unified Leyte geothermal power plants; 172.5 MW Palinpinon geothermal power plants; 140.0 MW Bac-Man geothermal power plants; 123.0 MW Tongonan geothermal power plant; 106.0 MW Mindanao geothermal power plants; 49.4 MW Nasulo geothermal power plant; 150 MW Burgos Wind Energy project; 6.82 MW Burgos Solar Energy project; and 5.17 MW Solar Rooftop projects. The FG Hydro segment operates Pantabangan-Masiway, a 132 MW Hydroelectric Plant. It sells its electricity to Manila Electric Company, National Power Corporation, electric cooperatives, privately-owned distribution utilities, large industrial clients, and National Grid Corporation of the Philippines. As of December 31, 2021, the company had an installed capacity of 3,495 megawatts (MW). First Gen Corporation was incorporated in 1998 and is based in Pasig, the Philippines. First Gen Corporation is a subsidiary of First Philippine Holdings Corporation.
Full FSGCY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.